Company Profile
Updated: 27-OCT-09GlaxoSmithKline Biologicals S.A./NV
Non-Quoted Public Company
rue de l'Institut 89, Rixensart, B-1330, Belgium
()32 02 656 81 11, 32 02 656 80 00 fax, http://www.gsk-bio.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Research, development and manufacture of vaccines
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/4/2009; 1607 words; ...for interrogating biological samples. ARC Pharmaceuticals...disclosed. Crucell NV, of Leiden, the...develop GenVec's lead cardiovascular...milestone payment from GlaxoSmithKline plc, of London...investigate at two U.S. centers the safety...guilty Monday in U.S. District Court...
TecTrends Reporter: Biotechnology Key Recent Media Coverage, Issue 09Q2.
M2 Presswire; 9/14/2009; 1982 words; ...stem cell research, biological and medical nanotechnology...Corp - Children's Hospital of Philadelphia...Tech) - Gevo Inc - GlaxoSmithKline plc - Harvard University...JGI) - King's College London...Koninklijke DSM NV - Koninklijke Philips...Inc - Novozymes A/S - OncoGenex ...
Belgium : Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in milestone payments.
TendersInfo; 1/6/2009; 774 words; ...Byline: pinto03 Galapagos NV (Euronext: GLPG) announced...osteoarthritis alliance with GlaxoSmithKline (GSK). Galapagos also...all the chemical and biological criteria set by GSK for...modifying drugs for GSK's global R&D organization...drug targets. "Today's announced milestones...
Financings Roundup Ascent's GPCR-Targeting Work Premiers with Funding, CEO.
BIOWORLD Today; 11/18/2008; 1192 words; ...technology a "new biological platform with widespread...applicability." "It's equivalent to being...the cell membrane's lipid bilayer structure...participated in Ascent's founding. EPIX had...billion deal with GlaxoSmithKline plc for the discovery...bio company Devgen NV, where he ...
GSK Pays Affiris $28M Up Front in Alzheimer's Vaccine Deal.
BIOWORLD Today; 10/27/2008; 1480 words; ...Hollingsworth, Staff Writer GlaxoSmithKline Biologicals SA, of Rixensart, Belgium...exclusive rights to Affiris's Alzheimer's disease...impaired in Alzheimer's disease. (See BioWorld...Ingelheim GmbH and Belgium's Ablynx NV extended their Alzheimer...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning